| |
| |
|
| Insider
Information: |
Bolte Axel |
| Relationship: |
Chief Executive Office... |
| City: |
South Plainfield |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
281,890 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$571,400 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
281,890 |
|
|
| Total
Value |
$571,400 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PTC Therapeutics, Inc. |
PTCT |
Director |
2013-06-25 |
20,000 |
2013-06-25 |
0 |
Premium* |
|
|
Iveric Bio Inc |
ISEE |
Director |
2023-07-11 |
0 |
2013-09-25 |
0 |
Premium* |
|
|
Inozyme Pharma, Inc. |
INZY |
Chief Executive Office... |
2022-09-30 |
261,890 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2023-07-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(22,088) |
0 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2023-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,588 |
22,088 |
0 |
- |
|
| INZY |
Inozyme Pharma, Inc. |
Chief Executive Officer |
• • – |
2022-09-30 |
4 |
A |
$2.28 |
$7,558 |
D/D |
3,315 |
261,890 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2022-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| INZY |
Inozyme Pharma, Inc. |
Chief Executive Officer |
• • – |
2022-04-19 |
4 |
B |
$3.69 |
$249,998 |
D/D |
67,750 |
258,575 |
2.81 |
- |
|
| INZY |
Inozyme Pharma, Inc. |
Chief Executive Officer |
• • – |
2021-06-24 |
4 |
S |
$0.00 |
$7 |
D/D |
(66,788) |
190,825 |
0 |
- |
|
| INZY |
Inozyme Pharma, Inc. |
Chief Executive Officer |
• • – |
2021-06-24 |
4 |
OE |
$0.98 |
$65,452 |
D/D |
66,788 |
257,613 |
0 |
- |
|
| INZY |
Inozyme Pharma, Inc. |
See RemarksOfficer |
• • • |
2020-07-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
190,825 |
|
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2016-12-30 |
4 |
S |
$4.83 |
$28,980 |
D/D |
(6,000) |
0 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2016-06-03 |
4 |
B |
$56.97 |
$199,395 |
D/D |
3,500 |
6,000 |
2.39 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2015-03-30 |
4 |
B |
$48.27 |
$24,135 |
D/D |
500 |
2,500 |
2.39 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2013-09-25 |
4 |
S |
$22.00 |
$44,000 |
D/D |
(2,000) |
2,000 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • – |
2013-06-25 |
4 |
B |
$15.00 |
$300,000 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
